Overview
Aave (AAVE) and Injective (INJ) sit at different layers of the crypto stack. At current prices ($92.06 vs $5.01), market leadership still favors Aave on capitalization, while 24h tape is led by Injective.
Quick winners
Full comparison
| Metric | AAVE | INJ |
|---|---|---|
| Price | $92.06 | $5.01 |
| Market Cap | $1.48B | $490.41M |
| FDV | — | — |
| Volume 24h | $14.06M | $2.77M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 52.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | AAVE | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +0.14% | +2.04% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | AAVE | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.07 |
| Trend | bearish | neutral |
| Momentum | 67.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Automated technical notes for this pair highlight bearish conditions on AAVE and neutral on INJ. Volatility differences can amplify short-term gaps.
Fundamentals
| Metric | AAVE | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | 0.00 |
| Github activity | 1,439.00 | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Aave
Injective
Pros and cons
Pros of Aave
- Composite PEPS readings for Aave can surface clearer module agreement during trend phases.
- Aave typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
Cons of Aave
- Regulatory or macro headlines can hit Aave harder simply because it is more visible.
- Indicator stacks on Aave may stay stretched longer than expected in strong trends.
Pros of Injective
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
Cons of Injective
- Smaller book depth versus large caps can increase slippage for Injective.
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
Which looks stronger right now?
Across winners above, no single coin dominates every column. Prefer scenarios: trend continuation favors the side with aligned momentum; mean-reversion favors the side stretched on RSI.
AI summary
This AI-assisted summary starts from live PEPS fields. Aave holds market-cap $1.48B and rank #52; Injective shows $490.41M and #99. Where liquidity and flow matter, watch Aave. Where durability matters, watch Aave. AI composite scores (57.90/47.20) compress those tensions into a single lens. In probabilistic terms, the side winning more columns may have a nearer-term edge, but tails remain fat. Revisit after the next hourly refresh.
FAQ
Which is better, Aave or Injective?
“Better” depends on horizon and risk. Aave leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, AAVE or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Aave and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Aave currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.